Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 11, 2007, Pages 1583-1584

  Date, Abhijit A ^a   Nagarsenker, Mangal S ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN;

AREA UNDER THE CURVE; BIOSYNTHESIS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; LETTER; LIVER; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PHARMACOKINETICS;

ADMINISTRATION, ORAL; ANIMALS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; EMULSIONS; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LIVER; PYRROLES; TISSUE DISTRIBUTION;

EID: 35948995848     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.11.0017     Document Type: Letter

References (11)

1. Gonzalez, R. C. B., Huwyler, J., Boess, F., Walter, I., Bittner, B. (2004) In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. Biopharm. Drug. Dispos. 25: 37-49
2. Holm, R., Porter, C. J. H., Edwards, G. A., Mullertz, A., Kristensen, H. G., Charman, W. N. (2003) Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur. J.Pharm. Sci. 20: 91-97
3. Kawakami, K., Yoshikawa, T., Hayashib, T., Nishihara, Y., Masuda, K. (2002) Microemulsion formulation for enhanced absorption of poorly soluble drugs II. In vivo study. J. Control. Release 81: 65-74
4. Lennernas, H. (2003) Clinical pharmacokinetics of atorvastatin. Clin. Pharmacokinet. 42: 1141-1160
5. Malhotra, H. S., Goa, K. L. (2001) Atorvastatin. Drugs 61: 1835-1881
6. O'Driscoll, C. M. (2002) Lipid-based formulation for intestinal lym-phatic delivery. Eur. J. Pharm. Sci. 15: 405-415
7. Porter, C. J. H., Charman, W. N. (1997) Uptake of drugs into the intestinal lymphatics after oral administration. Adv. Drug Deliv. Rev. 25:71-89
8. Sher, H., Zhong, M. (2006) Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Parm. Pharmacol. 58: 1183-1191
9. Stancu, C., Sima, A. (2001) Statins: mechanism of action and effects. J. Cell. Mol. Med. 5: 378-387
10. Tomlinson, B., Chan, P., Lan, W. (2001) How well tolerated are lipid-lowering drugs? Drugs Aging 18: 665-683
11. Wei, L., Sun, P., Nie, S., Pan, W. (2005) Preparation and evaluation of SEDDS and SMEDDS containing Carvedilol. Drug Dev. Ind. Pharm. 31:785-794